| 1 |
30008820 | Growth inhibition of human hepatocellular carcinoma cells by antagonism of the β2 adrenergic receptor. | 2018 Aug |
1 |
| 2 |
23261005 | Impact of β(1)- and β(2)-adrenergic receptor gene single nucleotide polymorphisms on heart rate response to metoprolol prior to coronary computed tomographic angiography. | 2013 Mar 1 |
1 |
| 3 |
23489141 | PDE3, but not PDE4, reduces β₁ - and β₂-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients. | 2013 Jun |
1 |
| 4 |
17671401 | Beta-2-adrenergic receptor polymorphisms and changes in lipids induced by metoprolol. | 2007 |
1 |
| 5 |
1591462 | Quantification of metoprolol beta 2-adrenoceptor antagonism in asthmatic patients by pharmacokinetic-pharmacodynamic modelling. | 1992 |
2 |
| 6 |
1848636 | Debrisoquine phenotype and the pharmacokinetics and beta-2 receptor pharmacodynamics of metoprolol and its enantiomers. | 1991 Mar |
1 |
| 7 |
2179287 | Tolerability and well-being with metoprolol in a controlled release (CR/ZOK) formulation: a review article. | 1990 Feb |
1 |
| 8 |
2565392 | A nonsteady-state agonist antagonist interaction model using plasma potassium concentrations to quantify the beta-2 selectivity of beta blockers. | 1989 Apr |
1 |
| 9 |
2836204 | Controlled-release metoprolol compared with atenolol in asthmatic patients: interaction with terbutaline. | 1988 |
1 |
| 10 |
6134510 | What is preferable in unstable angina, beta-blockade or calcium-inhibition? | 1983 Feb |
1 |